PubRank

Ronglih Liao

Author PubWeight™ 136.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011 6.36
2 Evidence for human lung stem cells. N Engl J Med 2011 5.67
3 Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005 5.48
4 Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 2002 3.22
5 CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005 3.03
6 Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009 2.44
7 Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A 2010 2.41
8 Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation 2007 2.26
9 Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004 2.25
10 Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007 2.23
11 Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 2005 2.18
12 Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res 2011 2.06
13 Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 2006 2.02
14 Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res 2003 1.99
15 Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 2007 1.92
16 PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility. Circ Res 2006 1.80
17 Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res 2014 1.78
18 mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 2013 1.72
19 Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood 2011 1.64
20 A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol 2009 1.63
21 Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem 2003 1.60
22 Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 2009 1.55
23 Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 2004 1.52
24 Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 2005 1.49
25 Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease. Proc Natl Acad Sci U S A 2013 1.48
26 The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol 2006 1.41
27 Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol 2005 1.38
28 Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 2005 1.37
29 Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol 2006 1.34
30 Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem 2004 1.33
31 Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res 2008 1.31
32 Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox. Circulation 2004 1.29
33 Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J Biol Chem 2005 1.25
34 Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002 1.24
35 Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 2006 1.21
36 Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 2010 1.20
37 Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation 2008 1.20
38 MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res 2013 1.19
39 A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 2008 1.18
40 Redox-mediated reciprocal regulation of SERCA and Na+-Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. Free Radic Biol Med 2010 1.17
41 Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res 2011 1.13
42 A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 2009 1.12
43 Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol 2011 1.11
44 Titin determines the Frank-Starling relation in early diastole. J Gen Physiol 2003 1.10
45 Microstructural impact of ischemia and bone marrow-derived cell therapy revealed with diffusion tensor magnetic resonance imaging tractography of the heart in vivo. Circulation 2014 1.10
46 Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Am J Physiol Heart Circ Physiol 2006 1.10
47 Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium. Circ Cardiovasc Imaging 2011 1.07
48 Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 2004 1.07
49 Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2006 1.06
50 Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res 2010 1.06
51 Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol 2013 1.06
52 Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation 2011 1.06
53 Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med 2003 1.05
54 Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. J Clin Invest 2008 1.04
55 Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol 2011 1.04
56 Nanoparticles targeting the infarcted heart. Nano Lett 2011 1.03
57 A novel microfluidic impedance assay for monitoring endothelin-induced cardiomyocyte hypertrophy. Biosens Bioelectron 2006 0.99
58 Cardiac side population cells: moving toward the center stage in cardiac regeneration. Circ Res 2012 0.98
59 The paradoxical role of inflammation in cardiac repair and regeneration. J Cardiovasc Transl Res 2010 0.97
60 Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. Circulation 2008 0.96
61 Isolation of resident cardiac progenitor cells by Hoechst 33342 staining. Methods Mol Biol 2010 0.95
62 Simultaneous orientation and cellular force measurements in adult cardiac myocytes using three-dimensional polymeric microstructures. Cell Motil Cytoskeleton 2007 0.94
63 Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes. Circulation 2004 0.94
64 Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am J Physiol Heart Circ Physiol 2009 0.93
65 Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice. Circ Res 2009 0.93
66 Regional cardiac dysfunction and dyssynchrony in a murine model of afterload stress. PLoS One 2013 0.92
67 Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue Eng 2006 0.91
68 Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol 2013 0.91
69 Gradient static-strain stimulation in a microfluidic chip for 3D cellular alignment. Lab Chip 2014 0.90
70 Impedance-based monitoring of ongoing cardiomyocyte death induced by tumor necrosis factor-alpha. Biophys J 2009 0.90
71 Myocyte contractile activity modulates norepinephrine cytotoxicity and survival effects of neuregulin-1beta. Am J Physiol Cell Physiol 2003 0.90
72 Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload. Hypertension 2007 0.90
73 Real-time monitoring primary cardiomyocyte adhesion based on electrochemical impedance spectroscopy and electrical cell-substrate impedance sensing. Anal Chem 2008 0.89
74 Mesenchymal stem cells in the infarcted heart. Coron Artery Dis 2005 0.89
75 CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways. OMICS 2009 0.88
76 Microfluidics-assisted fabrication of gelatin-silica core-shell microgels for injectable tissue constructs. Biomacromolecules 2014 0.88
77 Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol 2002 0.88
78 Regeneration in heart disease-Is ECM the key? Life Sci 2012 0.87
79 AMPK isoform expression in the normal and failing hearts. J Mol Cell Cardiol 2012 0.87
80 PGC1α plays a critical role in TWEAK-induced cardiac dysfunction. PLoS One 2013 0.85
81 Yin and Yang of myocardial transforming growth factor-beta1: timing is everything. Circulation 2005 0.85
82 Adult stem cells and heart regeneration. Expert Rev Cardiovasc Ther 2007 0.84
83 Not all hypertrophy is created equal. Circ Res 2007 0.84
84 A systematic survey of lipids across mouse tissues. Am J Physiol Endocrinol Metab 2014 0.84
85 Adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo. PLoS One 2012 0.83
86 Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging 2013 0.83
87 Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine. Mol Cell Biochem 2003 0.82
88 Assessment of right ventricular structure and function in mouse model of pulmonary artery constriction by transthoracic echocardiography. J Vis Exp 2014 0.82
89 Pump to survive: novel cytoprotective strategies for cardiac progenitor cells. Circ Res 2008 0.81
90 Optimized ventricular restraint therapy: adjustable restraint is superior to standard restraint in an ovine model of ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2012 0.80
91 Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal 2014 0.80
92 ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells. Circ Res 2012 0.80
93 Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms. Am J Physiol Heart Circ Physiol 2009 0.80
94 Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein. Am J Physiol Heart Circ Physiol 2008 0.79
95 Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat. Fundam Clin Pharmacol 2009 0.79
96 Preventing cardiac remodeling: the combination of cell-based therapy and cardiac support therapy preserves left ventricular function in rodent model of myocardial ischemia. J Thorac Cardiovasc Surg 2010 0.79
97 Spot identification and quality control in cell-based microarrays. ACS Comb Sci 2012 0.77
98 Intervention of cardiomyocyte death based on real-time monitoring of cell adhesion through impedance sensing. Biosens Bioelectron 2009 0.77
99 Methods to study the proliferation and differentiation of cardiac side population (CSP) cells. Methods Mol Biol 2013 0.76
100 Ultrasonic assessment of myocardial microstructure. J Vis Exp 2014 0.76
101 Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med 2015 0.76
102 Intervention of cardiomyocyte death based on the impedance-sensing technique of monitoring cell adhesion. Conf Proc IEEE Eng Med Biol Soc 2009 0.76
103 Cell therapy in heart failure. Heart Fail Clin 2005 0.76
104 Genetic determinants of vascular oxidant stress and endothelial dysfunction. Congest Heart Fail 2005 0.75
105 Evolving cell-based therapies for heart failure patients. Curr Treat Options Cardiovasc Med 2008 0.75